Cbl-b−/− T Cells Demonstrate In Vivo Resistance to Regulatory T Cells but a Context-Dependent Resistance to TGF-β-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cbl-b−/− T Cells Demonstrate In Vivo Resistance to Regulatory T Cells but a Context-Dependent Resistance to TGF-β

Published:2010-07-12 Issue:4 Volume:185 Page:2051-2058
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Adams Catherine O.,Housley William J.,Bhowmick Sourojit,Cone Robert E.,Rajan Thiruchandurai V.,Forouhar Faripour,Clark Robert B.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference42 articles.

1. Proteolysis-independent regulation of PI3K by Cbl-b–mediated ubiquitination in T cells

2. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b

3. Cbl-b regulates the CD28 dependence of T-cell activation

4. Essential Role of the E3 Ubiquitin Ligase Cbl-b in T Cell Anergy Induction

5. The E3 Ubiquitin Ligase Cbl-b Regulates Expansion but Not Functional Activity of Self-Reactive CD4 T Cells

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retinopathy as an initial sign of hereditary immunological diseases: report of six families and challenges in eye clinic;Frontiers in Immunology;2023-08-28

2. CBLB Deficiency in Human CD4+ T Cells Results in Resistance to T Regulatory Suppression through Multiple Mechanisms;The Journal of Immunology;2022-10-01

3. Boosting regulatory T cell function for the treatment of autoimmune diseases – That’s only half the battle!;Frontiers in Immunology;2022-08-10

4. Overproduction of IFNγ by Cbl-b–Deficient CD8+ T Cells Provides Resistance against Regulatory T Cells and Induces Potent Antitumor Immunity;Cancer Immunology Research;2022-02-18

5. Emerging Role of Ubiquitination in the Regulation of PD-1/PD-L1 in Cancer Immunotherapy;Molecular Therapy;2021-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3